Obesity and GLP-1 Dealmaking: Strategic Trends and Market Signals
The global market for obesity therapeutics has undergone a seismic shift, catalyzed by the rise of GLP-1-based therapies which in turn has driven a surge in strategic dealmaking.
Foreword
Deal Trends in Obesity
The obesity market remains an attractive proposition
Deal activity across development stages
Trends by Asset Target
China emerges as a source of innovation
Biopharma continues to provide attractive opportunities for investors
How Evaluate Helps